4//SEC Filing
ARIAD PHARMACEUTICALS INC 4
Accession 0000884731-16-000024
CIK 0000884731operating
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:02 PM ET
Size
8.9 KB
Accession
0000884731-16-000024
Insider Transaction Report
Form 4
BERSTEIN DAVID L
Senior VP, Chief IP Officer
Transactions
- Sale
Common Stock
2016-03-21$6.47/sh−2,375$15,356→ 262,115 total - Exercise/Conversion
Common Stock
2016-03-19+4,750→ 264,490 total - Exercise/Conversion
Restricted Stock Units
2016-03-19−4,750→ 0 total→ Common Stock (4,750 underlying)
Footnotes (5)
- [F1]Shares were acquired upon the vesting of a Restricted Stock Unit dated 03/19/2013
- [F2]Represents shares sold to satisfy withholding tax requirements pursuant to a Rule 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.27 to $6.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer,or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
- [F4]Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- [F5]Restricted Stock Units vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016
Documents
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000884731
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:02 PM ET
- Size
- 8.9 KB